Sound Pharmaceuticals

About:

Sound Pharmaceuticals develops prescription drugs to prevent and treat sensorineural hearing loss.

Website: http://www.soundpharmaceuticals.com

Top Investors: KEC Ventures, Cystic Fibrosis Foundation, NCATS

Description:

Sound Pharmaceuticals is a biopharmaceutical company that develops prescription drugs that enable doctors and patients to prevent and treat hearing loss. It focuses on developing drug treatments for sensorineural hearing loss.

Total Funding Amount:

$37.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)soundpharmaceuticals.com

Founders:

Eric D. Lynch, Jonathan Kil

Number of Employees:

11-50

Last Funding Date:

2022-05-11

IPO Status:

Private

Industries: